Literature DB >> 16421512

Monoamine oxidase A activity and norepinephrine level in hippocampus determine hyperwheel running in SPORTS rats.

Masaki Morishima1, Nagakatsu Harada, Sayuri Hara, Atsuko Sano, Hiromasa Seno, Akira Takahashi, Yusuke Morita, Yutaka Nakaya.   

Abstract

An understanding of neurological mechanisms for wheel running by rodents, especially with high exercise activity, would be applicable to a strategy for promotion of exercise motivation in humans. One of several brain regions that are candidates for the regulation of physical exercise is the hippocampus. Here we examined the running activity of Spontaneously-Running-Tokushima-Shikoku (SPORTS) rat, a new animal model for high levels of wheel-running activity, and its relation with the hippocampal norepinephrine (NE) system including the levels of NE, adrenergic receptors, and degradation enzymes for monoamines. In the hippocampus of SPORTS rats, the level of NE in extracellular fluid was augmented, whereas the level in the homogenate of the whole tissue was decreased even for sedentary conditions. Elevated extracellular NE caused downregulation of alpha(2)-adrenergic receptors in the hippocampus of SPORTS rats. Local administration of alpha(2)-adrenergic receptor antagonist yohimbine, but not of alpha(2)-agonist clonidine, into the hippocampus suppressed high running activity in SPORTS rats. The protein expression and the activity levels of monoamine oxidase A (MAOA), a critical enzyme for the degradation of NE, were decreased in the hippocampus of SPORTS rats to increase extracellular NE level. Thus, inhibition of oxidase activity in normal Wistar rats markedly increased wheel-running activity. These results indicate that decreased MAOA activity, elevation of extracellular NE, and alpha(2)-adrenergic receptors in the hippocampus determine the neural basis of the psychological regulation of exercise behavior in SPORTS rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16421512     DOI: 10.1038/sj.npp.1301028

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  17 in total

Review 1.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

2.  The yeast product Milmed enhances the effect of physical exercise on motor performance and dopamine neurochemistry recovery in MPTP-lesioned mice.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurotox Res       Date:  2013-07-27       Impact factor: 3.911

3.  Persistent exercise attenuates nicotine- but not clonidine-induced antinociception in female rats.

Authors:  Wendy Foulds Mathes; Robin B Kanarek
Journal:  Pharmacol Biochem Behav       Date:  2007-01-02       Impact factor: 3.533

4.  Exercise Improves Cognitive Impairment and Dopamine Metabolism in MPTP-Treated Mice.

Authors:  Aderbal S Aguiar; Samantha C Lopes; Fabrine S M Tristão; Daniel Rial; Gisele de Oliveira; Cláudio da Cunha; Rita Raisman-Vozari; Rui D Prediger
Journal:  Neurotox Res       Date:  2016-01       Impact factor: 3.911

Review 5.  The biological control of voluntary exercise, spontaneous physical activity and daily energy expenditure in relation to obesity: human and rodent perspectives.

Authors:  Theodore Garland; Heidi Schutz; Mark A Chappell; Brooke K Keeney; Thomas H Meek; Lynn E Copes; Wendy Acosta; Clemens Drenowatz; Robert C Maciel; Gertjan van Dijk; Catherine M Kotz; Joey C Eisenmann
Journal:  J Exp Biol       Date:  2011-01-15       Impact factor: 3.312

6.  Running wheel activity restores MPTP-induced functional deficits.

Authors:  Anders Fredriksson; Ingels Maria Stigsdotter; Anders Hurtig; Béatrice Ewalds-Kvist; Trevor Archer
Journal:  J Neural Transm (Vienna)       Date:  2010-09-18       Impact factor: 3.575

Review 7.  Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.

Authors:  Marco Bortolato; Jean C Shih
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

Review 8.  Pharmacomimetics of exercise: novel approaches for hippocampally-targeted neuroprotective agents.

Authors:  A M Stranahan; Y Zhou; B Martin; S Maudsley
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 9.  Exploring exercise as an avenue for the treatment of anxiety disorders.

Authors:  Lindsey B DeBoer; Mark B Powers; Angela C Utschig; Michael W Otto; Jasper A J Smits
Journal:  Expert Rev Neurother       Date:  2012-08       Impact factor: 4.618

Review 10.  The role of monoamine oxidase A in aggression: Current translational developments and future challenges.

Authors:  Sean C Godar; Paula J Fite; Kenneth M McFarlin; Marco Bortolato
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-01-09       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.